LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 13

Search options

  1. Article ; Online: Decoding the autoantibody reactome.

    Jaycox, Jillian R / Dai, Yile / Ring, Aaron M

    Science (New York, N.Y.)

    2024  Volume 383, Issue 6684, Page(s) 705–707

    Abstract: Autoantibodies influence a wide range of conditions beyond autoimmune diseases. ...

    Abstract Autoantibodies influence a wide range of conditions beyond autoimmune diseases.
    MeSH term(s) Humans ; Autoantibodies/genetics ; Autoantibodies/immunology ; Autoimmune Diseases/immunology ; Neoplasms/immunology ; Antigens, Neoplasm/immunology ; COVID-19/immunology ; Interferon Type I/immunology
    Chemical Substances Autoantibodies ; Antigens, Neoplasm ; Interferon Type I
    Language English
    Publishing date 2024-02-15
    Publishing country United States
    Document type Journal Article
    ZDB-ID 128410-1
    ISSN 1095-9203 ; 0036-8075
    ISSN (online) 1095-9203
    ISSN 0036-8075
    DOI 10.1126/science.abn1034
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: SARS-CoV-2 mRNA vaccines decouple anti-viral immunity from humoral autoimmunity.

    Jaycox, Jillian R / Lucas, Carolina / Yildirim, Inci / Dai, Yile / Wang, Eric Y / Monteiro, Valter / Lord, Sandra / Carlin, Jeffrey / Kita, Mariko / Buckner, Jane H / Ma, Shuangge / Campbell, Melissa / Ko, Albert / Omer, Saad / Lucas, Carrie L / Speake, Cate / Iwasaki, Akiko / Ring, Aaron M

    Nature communications

    2023  Volume 14, Issue 1, Page(s) 1299

    Abstract: mRNA-based vaccines dramatically reduce the occurrence and severity of COVID-19, but are associated with rare vaccine-related adverse effects. These toxicities, coupled with observations that SARS-CoV-2 infection is associated with autoantibody ... ...

    Abstract mRNA-based vaccines dramatically reduce the occurrence and severity of COVID-19, but are associated with rare vaccine-related adverse effects. These toxicities, coupled with observations that SARS-CoV-2 infection is associated with autoantibody development, raise questions whether COVID-19 vaccines may also promote the development of autoantibodies, particularly in autoimmune patients. Here we used Rapid Extracellular Antigen Profiling to characterize self- and viral-directed humoral responses after SARS-CoV-2 mRNA vaccination in 145 healthy individuals, 38 patients with autoimmune diseases, and 8 patients with mRNA vaccine-associated myocarditis. We confirm that most individuals generated robust virus-specific antibody responses post vaccination, but that the quality of this response is impaired in autoimmune patients on certain modes of immunosuppression. Autoantibody dynamics are remarkably stable in all vaccinated patients compared to COVID-19 patients that exhibit an increased prevalence of new autoantibody reactivities. Patients with vaccine-associated myocarditis do not have increased autoantibody reactivities relative to controls. In summary, our findings indicate that mRNA vaccines decouple SARS-CoV-2 immunity from autoantibody responses observed during acute COVID-19.
    MeSH term(s) Humans ; Antibodies, Viral/immunology ; Autoantibodies/immunology ; Autoimmune Diseases/immunology ; Autoimmunity/immunology ; COVID-19/immunology ; COVID-19/prevention & control ; COVID-19 Vaccines/adverse effects ; COVID-19 Vaccines/immunology ; COVID-19 Vaccines/therapeutic use ; Drug-Related Side Effects and Adverse Reactions/immunology ; Immunity, Humoral/immunology ; Myocarditis/immunology ; RNA, Messenger ; SARS-CoV-2 ; Vaccination ; Vaccines, Synthetic/adverse effects ; Vaccines, Synthetic/immunology ; Vaccines, Synthetic/therapeutic use ; mRNA Vaccines/adverse effects ; mRNA Vaccines/immunology ; mRNA Vaccines/therapeutic use
    Chemical Substances Antibodies, Viral ; Autoantibodies ; COVID-19 Vaccines ; RNA, Messenger ; Vaccines, Synthetic ; mRNA Vaccines
    Language English
    Publishing date 2023-03-09
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2553671-0
    ISSN 2041-1723 ; 2041-1723
    ISSN (online) 2041-1723
    ISSN 2041-1723
    DOI 10.1038/s41467-023-36686-8
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Impact of COVID-19 vaccination on symptoms and immune phenotypes in vaccine-naïve individuals with Long COVID.

    Grady, Connor B / Bhattacharjee, Bornali / Silva, Julio / Jaycox, Jillian / Lee, Lik Wee / Monteiro, Valter Silva / Sawano, Mitsuaki / Massey, Daisy / Caraballo, César / Gehlhausen, Jeff R / Tabachnikova, Alexandra / Mao, Tianyang / Lucas, Carolina / Peña-Hernandez, Mario A / Xu, Lan / Tzeng, Tiffany J / Takahashi, Takehiro / Herrin, Jeph / Güthe, Diana Berrent /
    Akrami, Athena / Assaf, Gina / Davis, Hannah / Harris, Karen / McCorkell, Lisa / Schulz, Wade L / Grffin, Daniel / Wei, Hannah / Ring, Aaron M / Guan, Leying / Cruz, Charles Dela / Iwasaki, Akiko / Krumholz, Harlan M

    medRxiv : the preprint server for health sciences

    2024  

    Abstract: Background: Long COVID contributes to the global burden of disease. Proposed root cause hypotheses include the persistence of SARS-CoV-2 viral reservoir, autoimmunity, and reactivation of latent herpesviruses. Patients have reported various changes in ... ...

    Abstract Background: Long COVID contributes to the global burden of disease. Proposed root cause hypotheses include the persistence of SARS-CoV-2 viral reservoir, autoimmunity, and reactivation of latent herpesviruses. Patients have reported various changes in Long COVID symptoms after COVID-19 vaccinations, leaving uncertainty about whether vaccine-induced immune responses may alleviate or worsen disease pathology.
    Methods: In this prospective study, we evaluated changes in symptoms and immune responses after COVID-19 vaccination in 16 vaccine-naïve individuals with Long COVID. Surveys were administered before vaccination and then at 2, 6, and 12 weeks after receiving the first vaccine dose of the primary series. Simultaneously, SARS-CoV-2-reactive TCR enrichment, SARS-CoV-2-specific antibody responses, antibody responses to other viral and self-antigens, and circulating cytokines were quantified before vaccination and at 6 and 12 weeks after vaccination.
    Results: Self-report at 12 weeks post-vaccination indicated 10 out of 16 participants had improved health, 3 had no change, 1 had worse health, and 2 reported marginal changes. Significant elevation in SARS-CoV-2-specific TCRs and Spike protein-specific IgG were observed 6 and 12 weeks after vaccination. No changes in reactivities were observed against herpes viruses and self-antigens. Within this dataset, higher baseline sIL-6R was associated with symptom improvement, and the two top features associated with non-improvement were high IFN-β and CNTF, among soluble analytes.
    Conclusions: Our study showed that in this small sample, vaccination improved the health or resulted in no change to the health of most participants, though few experienced worsening. Vaccination was associated with increased SARS-CoV-2 Spike protein-specific IgG and T cell expansion in most individuals with Long COVID. Symptom improvement was observed in those with baseline elevated sIL-6R, while elevated interferon and neuropeptide levels were associated with a lack of improvement.
    Language English
    Publishing date 2024-01-12
    Publishing country United States
    Document type Preprint
    DOI 10.1101/2024.01.11.24300929
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Cytokinopathy with aberrant cytotoxic lymphocytes and profibrotic myeloid response in SARS-CoV-2 mRNA vaccine-associated myocarditis.

    Barmada, Anis / Klein, Jon / Ramaswamy, Anjali / Brodsky, Nina N / Jaycox, Jillian R / Sheikha, Hassan / Jones, Kate M / Habet, Victoria / Campbell, Melissa / Sumida, Tomokazu S / Kontorovich, Amy / Bogunovic, Dusan / Oliveira, Carlos R / Steele, Jeremy / Hall, E Kevin / Pena-Hernandez, Mario / Monteiro, Valter / Lucas, Carolina / Ring, Aaron M /
    Omer, Saad B / Iwasaki, Akiko / Yildirim, Inci / Lucas, Carrie L

    Science immunology

    2023  Volume 8, Issue 83, Page(s) eadh3455

    Abstract: Rare immune-mediated cardiac tissue inflammation can occur after vaccination, including after SARS-CoV-2 mRNA vaccines. However, the underlying immune cellular and molecular mechanisms driving this pathology remain poorly understood. Here, we ... ...

    Abstract Rare immune-mediated cardiac tissue inflammation can occur after vaccination, including after SARS-CoV-2 mRNA vaccines. However, the underlying immune cellular and molecular mechanisms driving this pathology remain poorly understood. Here, we investigated a cohort of patients who developed myocarditis and/or pericarditis with elevated troponin, B-type natriuretic peptide, and C-reactive protein levels as well as cardiac imaging abnormalities shortly after SARS-CoV-2 mRNA vaccination. Contrary to early hypotheses, patients did not demonstrate features of hypersensitivity myocarditis, nor did they have exaggerated SARS-CoV-2-specific or neutralizing antibody responses consistent with a hyperimmune humoral mechanism. We additionally found no evidence of cardiac-targeted autoantibodies. Instead, unbiased systematic immune serum profiling revealed elevations in circulating interleukins (IL-1β, IL-1RA, and IL-15), chemokines (CCL4, CXCL1, and CXCL10), and matrix metalloproteases (MMP1, MMP8, MMP9, and TIMP1). Subsequent deep immune profiling using single-cell RNA and repertoire sequencing of peripheral blood mononuclear cells during acute disease revealed expansion of activated CXCR3
    MeSH term(s) Humans ; Myocarditis/etiology ; SARS-CoV-2 ; Leukocytes, Mononuclear ; COVID-19 Vaccines/adverse effects ; Contrast Media ; COVID-19/prevention & control ; Gadolinium ; Antineoplastic Agents ; Killer Cells, Natural ; Cytokines
    Chemical Substances COVID-19 Vaccines ; Contrast Media ; Gadolinium (AU0V1LM3JT) ; Antineoplastic Agents ; Cytokines
    Language English
    Publishing date 2023-05-05
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ISSN 2470-9468
    ISSN (online) 2470-9468
    DOI 10.1126/sciimmunol.adh3455
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Impact of COVID-19 vaccination on symptoms and immune phenotypes in vaccine-naïve individuals with Long COVID

    Grady, Connor B / Bhattacharjee, Bornali / Silva, Julio / Jaycox, Jillian / Lee, Lik Wee / Monteiro, Valter Silva / Sawano, Mitsuaki / Massey, Daisy / Caraballo, César / Gehlhausen, Jeff R. / Tabachnikova, Alexandra / Mao, Tianyang / Lucas, Carolina / Peña-Hernandez, Mario A. / Xu, Lan / Tzeng, Tiffany J. / Takahashi, Takehiro / Herrin, Jeph / Güthe, Diana Berrent /
    Akrami, Athena / Assaf, Gina / Davis, Hannah / Harris, Karen / McCorkell, Lisa / Schulz, Wade L / Grffin, Daniel / Wei, Hannah / Ring, Aaron M / Guan, Leying / Cruz, Charles Dela / Iwasaki, Akiko / Krumholz, Harlan M

    medRxiv

    Abstract: Background: Long COVID contributes to the global burden of disease. Proposed root cause hypotheses include the persistence of SARS-CoV-2 viral reservoir, autoimmunity, and reactivation of latent herpesviruses. Patients have reported various changes in ... ...

    Abstract Background: Long COVID contributes to the global burden of disease. Proposed root cause hypotheses include the persistence of SARS-CoV-2 viral reservoir, autoimmunity, and reactivation of latent herpesviruses. Patients have reported various changes in Long COVID symptoms after COVID-19 vaccinations, leaving uncertainty about whether vaccine-induced immune responses may alleviate or worsen disease pathology. Methods: In this prospective study, we evaluated changes in symptoms and immune responses after COVID-19 vaccination in 16 vaccine-naïve individuals with Long COVID. Surveys were administered before vaccination and then at 2, 6, and 12 weeks after receiving the first vaccine dose of the primary series. Simultaneously, SARS-CoV-2-reactive TCR enrichment, SARS-CoV-2-specific antibody responses, antibody responses to other viral and self-antigens, and circulating cytokines were quantified before vaccination and at 6 and 12 weeks after vaccination. Results: Self-report at 12 weeks post-vaccination indicated 10 out of 16 participants had improved health, 3 had no change, 1 had worse health, and 2 reported marginal changes. Significant elevation in SARS-CoV-2-specific TCRs and Spike protein-specific IgG were observed 6 and 12 weeks after vaccination. No changes in reactivities were observed against herpes viruses and self-antigens. Within this dataset, higher baseline sIL-6R was associated with symptom improvement, and the two top features associated with non-improvement were high IFN-β and CNTF, among soluble analytes. Conclusions: Our study showed that in this small sample, vaccination improved the health or resulted in no change to the health of most participants, though few experienced worsening. Vaccination was associated with increased SARS-CoV-2 Spike protein-specific IgG and T cell expansion in most individuals with Long COVID. Symptom improvement was observed in those with baseline elevated sIL-6R, while elevated interferon and neuropeptide levels were associated with a lack of improvement.
    Keywords covid19
    Language English
    Publishing date 2024-01-12
    Publisher Cold Spring Harbor Laboratory Press
    Document type Article ; Online
    DOI 10.1101/2024.01.11.24300929
    Database COVID19

    Kategorien

  6. Article: Distinguishing features of Long COVID identified through immune profiling.

    Klein, Jon / Wood, Jamie / Jaycox, Jillian / Lu, Peiwen / Dhodapkar, Rahul M / Gehlhausen, Jeff R / Tabachnikova, Alexandra / Tabacof, Laura / Malik, Amyn A / Kamath, Kathy / Greene, Kerrie / Monteiro, Valter Silva / Peña-Hernandez, Mario / Mao, Tianyang / Bhattacharjee, Bornali / Takahashi, Takehiro / Lucas, Carolina / Silva, Julio / Mccarthy, Dayna /
    Breyman, Erica / Tosto-Mancuso, Jenna / Dai, Yile / Perotti, Emily / Akduman, Koray / Tzeng, Tiffany J / Xu, Lan / Yildirim, Inci / Krumholz, Harlan M / Shon, John / Medzhitov, Ruslan / Omer, Saad B / van Dijk, David / Ring, Aaron M / Putrino, David / Iwasaki, Akiko

    medRxiv : the preprint server for health sciences

    2022  

    Abstract: SARS-CoV-2 infection can result in the development of a constellation of persistent sequelae following acute disease called post-acute sequelae of COVID-19 (PASC) or Long ... ...

    Abstract SARS-CoV-2 infection can result in the development of a constellation of persistent sequelae following acute disease called post-acute sequelae of COVID-19 (PASC) or Long COVID
    Language English
    Publishing date 2022-08-10
    Publishing country United States
    Document type Preprint
    DOI 10.1101/2022.08.09.22278592
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Lack of association between pandemic chilblains and SARS-CoV-2 infection.

    Gehlhausen, Jeff R / Little, Alicia J / Ko, Christine J / Emmenegger, Marc / Lucas, Carolina / Wong, Patrick / Klein, Jon / Lu, Peiwen / Mao, Tianyang / Jaycox, Jillian / Wang, Eric / Ugwu, Nelson / Muenker, Cate / Mekael, Dilgash / Klein, Rhonda Q / Patrignelli, Robert / Antaya, Richard / McNiff, Jennifer / Damsky, William /
    Kamath, Kathy / Shon, John / Ring, Aaron M / Yildirim, Inci / Omer, Saad / Ko, Albert I / Aguzzi, Adriano / Iwasaki, Akiko

    Proceedings of the National Academy of Sciences of the United States of America

    2022  Volume 119, Issue 9

    Abstract: An increased incidence of chilblains has been observed during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic and attributed to viral infection. Direct evidence of this relationship has been limited, however, as most cases do ... ...

    Abstract An increased incidence of chilblains has been observed during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic and attributed to viral infection. Direct evidence of this relationship has been limited, however, as most cases do not have molecular evidence of prior SARS-CoV-2 infection with PCR or antibodies. We enrolled a cohort of 23 patients who were diagnosed and managed as having SARS-CoV-2-associated skin eruptions (including 21 pandemic chilblains [PC]) during the first wave of the pandemic in Connecticut. Antibody responses were determined through endpoint titration enzyme-linked immunosorbent assay and serum epitope repertoire analysis. T cell responses to SARS-CoV-2 were assessed by T cell receptor sequencing and in vitro SARS-CoV-2 antigen-specific peptide stimulation assays. Immunohistochemical and PCR studies of PC biopsies and tissue microarrays for evidence of SARS-CoV-2 were performed. Among patients diagnosed and managed as "covid toes" during the pandemic, we find a percentage of prior SARS-CoV-2 infection (9.5%) that approximates background seroprevalence (8.5%) at the time. Immunohistochemistry studies suggest that SARS-CoV-2 staining in PC biopsies may not be from SARS-CoV-2. Our results do not support SARS-CoV-2 as the causative agent of pandemic chilblains; however, our study does not exclude the possibility of SARS-CoV-2 seronegative abortive infections.
    MeSH term(s) Adult ; COVID-19/complications ; COVID-19/epidemiology ; Chilblains/epidemiology ; Chilblains/immunology ; Chilblains/virology ; Connecticut/epidemiology ; Female ; Humans ; Male ; Middle Aged ; Retrospective Studies ; SARS-CoV-2/immunology ; Young Adult
    Language English
    Publishing date 2022-02-25
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 209104-5
    ISSN 1091-6490 ; 0027-8424
    ISSN (online) 1091-6490
    ISSN 0027-8424
    DOI 10.1073/pnas.2122090119
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Signaling through IL-17C/IL-17RE is dispensable for immunity to systemic, oral and cutaneous candidiasis.

    Conti, Heather R / Whibley, Natasha / Coleman, Bianca M / Garg, Abhishek V / Jaycox, Jillian R / Gaffen, Sarah L

    PloS one

    2015  Volume 10, Issue 4, Page(s) e0122807

    Abstract: Candida albicans is a commensal fungal microbe of the human orogastrointestinal tract and skin. C. albicans causes multiple forms of disease in immunocompromised patients, including oral, vaginal, dermal and disseminated candidiasis. The cytokine IL-17 ( ... ...

    Abstract Candida albicans is a commensal fungal microbe of the human orogastrointestinal tract and skin. C. albicans causes multiple forms of disease in immunocompromised patients, including oral, vaginal, dermal and disseminated candidiasis. The cytokine IL-17 (IL-17A) and its receptor subunits, IL-17RA and IL-17RC, are required for protection to most forms of candidiasis. The importance of the IL-17R pathway has been observed not only in knockout mouse models, but also in humans with rare genetic mutations that impact generation of Th17 cells or the IL-17 signaling pathway, including Hyper-IgE Syndrome (STAT3 or TYK2 mutations) or IL17RA or ACT1 gene deficiency. The IL-17 family of cytokines is a distinct subclass of cytokines with unique structural and signaling properties. IL-17A is the best-characterized member of the IL-17 family to date, but far less is known about other IL-17-related cytokines. In this study, we sought to determine the role of a related IL-17 cytokine, IL-17C, in protection against oral, dermal and disseminated forms of C. albicans infection. IL-17C signals through a heterodimeric receptor composed of the IL-17RA and IL-17RE subunits. We observed that IL-17C mRNA was induced following oral C. albicans infection. However, mice lacking IL-17C or IL-17RE cleared C. albicans infections in the oral mucosa, skin and bloodstream at rates similar to WT littermate controls. Moreover, these mice demonstrated similar gene transcription profiles and recovery kinetics as WT animals. These findings indicate that IL-17C and IL-17RE are dispensable for immunity to the forms of candidiasis evaluated, and illustrate a surprisingly limited specificity of the IL-17 family of cytokines with respect to systemic, oral and cutaneous Candida infections.
    MeSH term(s) Animals ; Candidiasis/immunology ; Candidiasis/metabolism ; Candidiasis/pathology ; Candidiasis, Cutaneous/immunology ; Candidiasis, Cutaneous/metabolism ; Candidiasis, Cutaneous/pathology ; Candidiasis, Oral/immunology ; Candidiasis, Oral/metabolism ; Candidiasis, Oral/pathology ; Disease Resistance ; Female ; Interleukin-17/deficiency ; Interleukin-17/metabolism ; Male ; Mice ; Mice, Inbred C57BL ; Protein Subunits/deficiency ; Protein Subunits/metabolism ; Receptors, Interleukin-17/deficiency ; Receptors, Interleukin-17/metabolism ; Signal Transduction/immunology
    Chemical Substances Il17c protein, mouse ; Interleukin-17 ; Protein Subunits ; Receptors, Interleukin-17
    Language English
    Publishing date 2015-04-07
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 2267670-3
    ISSN 1932-6203 ; 1932-6203
    ISSN (online) 1932-6203
    ISSN 1932-6203
    DOI 10.1371/journal.pone.0122807
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Distinguishing features of long COVID identified through immune profiling.

    Klein, Jon / Wood, Jamie / Jaycox, Jillian R / Dhodapkar, Rahul M / Lu, Peiwen / Gehlhausen, Jeff R / Tabachnikova, Alexandra / Greene, Kerrie / Tabacof, Laura / Malik, Amyn A / Silva Monteiro, Valter / Silva, Julio / Kamath, Kathy / Zhang, Minlu / Dhal, Abhilash / Ott, Isabel M / Valle, Gabrielee / Peña-Hernández, Mario / Mao, Tianyang /
    Bhattacharjee, Bornali / Takahashi, Takehiro / Lucas, Carolina / Song, Eric / McCarthy, Dayna / Breyman, Erica / Tosto-Mancuso, Jenna / Dai, Yile / Perotti, Emily / Akduman, Koray / Tzeng, Tiffany J / Xu, Lan / Geraghty, Anna C / Monje, Michelle / Yildirim, Inci / Shon, John / Medzhitov, Ruslan / Lutchmansingh, Denyse / Possick, Jennifer D / Kaminski, Naftali / Omer, Saad B / Krumholz, Harlan M / Guan, Leying / Dela Cruz, Charles S / van Dijk, David / Ring, Aaron M / Putrino, David / Iwasaki, Akiko

    Nature

    2023  Volume 623, Issue 7985, Page(s) 139–148

    Abstract: Post-acute infection syndromes may develop after acute viral ... ...

    Abstract Post-acute infection syndromes may develop after acute viral disease
    MeSH term(s) Humans ; Antibodies, Viral/blood ; Antibodies, Viral/immunology ; Biomarkers/blood ; Cross-Sectional Studies ; Herpesvirus 4, Human/immunology ; Hydrocortisone/blood ; Immunophenotyping ; Lymphocytes/immunology ; Machine Learning ; Myeloid Cells/immunology ; Post-Acute COVID-19 Syndrome/diagnosis ; Post-Acute COVID-19 Syndrome/immunology ; Post-Acute COVID-19 Syndrome/physiopathology ; Post-Acute COVID-19 Syndrome/virology ; SARS-CoV-2/immunology
    Chemical Substances Antibodies, Viral ; Biomarkers ; Hydrocortisone (WI4X0X7BPJ)
    Language English
    Publishing date 2023-09-25
    Publishing country England
    Document type Journal Article
    ZDB-ID 120714-3
    ISSN 1476-4687 ; 0028-0836
    ISSN (online) 1476-4687
    ISSN 0028-0836
    DOI 10.1038/s41586-023-06651-y
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Diverse functional autoantibodies in patients with COVID-19.

    Wang, Eric Y / Mao, Tianyang / Klein, Jon / Dai, Yile / Huck, John D / Jaycox, Jillian R / Liu, Feimei / Zhou, Ting / Israelow, Benjamin / Wong, Patrick / Coppi, Andreas / Lucas, Carolina / Silva, Julio / Oh, Ji Eun / Song, Eric / Perotti, Emily S / Zheng, Neil S / Fischer, Suzanne / Campbell, Melissa /
    Fournier, John B / Wyllie, Anne L / Vogels, Chantal B F / Ott, Isabel M / Kalinich, Chaney C / Petrone, Mary E / Watkins, Anne E / Dela Cruz, Charles / Farhadian, Shelli F / Schulz, Wade L / Ma, Shuangge / Grubaugh, Nathan D / Ko, Albert I / Iwasaki, Akiko / Ring, Aaron M

    Nature

    2021  Volume 595, Issue 7866, Page(s) 283–288

    Abstract: COVID-19 manifests with a wide spectrum of clinical phenotypes that are characterized by exaggerated and misdirected host immune ... ...

    Abstract COVID-19 manifests with a wide spectrum of clinical phenotypes that are characterized by exaggerated and misdirected host immune responses
    MeSH term(s) Animals ; Antigens, Surface/immunology ; Autoantibodies/analysis ; Autoantibodies/immunology ; COVID-19/immunology ; COVID-19/metabolism ; COVID-19/pathology ; COVID-19/physiopathology ; Case-Control Studies ; Complement System Proteins/immunology ; Cytokines/immunology ; Disease Models, Animal ; Disease Progression ; Female ; Humans ; Male ; Mice ; Organ Specificity/immunology ; Proteome/immunology ; Proteome/metabolism
    Chemical Substances Antigens, Surface ; Autoantibodies ; Cytokines ; Proteome ; Complement System Proteins (9007-36-7)
    Language English
    Publishing date 2021-05-19
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 120714-3
    ISSN 1476-4687 ; 0028-0836
    ISSN (online) 1476-4687
    ISSN 0028-0836
    DOI 10.1038/s41586-021-03631-y
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top